A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Agonists of TREM2
Assignee: Genentech, Inc. Patent Number: 12,384,844 Filing Date: May 12, 2022 (priority to May 14, 2021) Patent Issued: August 12, 2025 Inventors: Ainhoa Echeverria Larraza, David Verne Hansen, Yi-Chun Hsiao, Zhonghua Lin, Dhaya Seshasayee, Benny…
-
Semaglutide in Medical Therapy
Assignee: Novo Nordisk A/S Filed: August 30, 2024 Patent Granted: May 13, 2025 Publication Number: US20240415935 (application) / US12,295,988 (grant) Inventors: Lars Holm Damgaard, Soeren Oestergaard Hardt-Lindberg, Thomas Hansen What This Patent Covers This patent…
-
Targeted Expression of Regeneration Factors in Aged/Senescent Cells
Publication: WO2025/208002 (international patent application filed by Altos Labs, Inc.) What the Patent Covers This patent application focuses on methods and materials for selectively expressing regeneration factors specifically in aged or senescent cells—the cells that…
